A new study by investigators from Mass General Brigham suggests that gabapentin, a relatively common anti-seizure/pain medication, is linked to improved survival in patients with glioblastoma (GBM) — the most common and deadly form of brain cancer in adults. The findings, published in Nature Communications, are based on a retrospective analysis and add new evidence to help patients with this devastating disease.

A recent study demonstrates that Aurora kinase inhibitors can induce functional differentiation in liver cancer cells, offering a potential therapeutic strategy for liver cancer.

Scientists at OHSU have created a new nanoparticle that could make ultrasound-based cancer treatments more effective and safer, while also helping prevent tumors from coming back. To make the therapy even more powerful, the scientists also attached a potent chemotherapy drug to the peptide on the nanoparticle’s surface. The ultrasound physically destroys the tumor, and the drug helps eliminate any leftover cancer cells that might cause the tumor to return.